PIQ Proteomics International Laboratories Limited
—Mkt Cap: —P/E: —1d ago
Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, and India. It provides PromarkerD, a blood t…
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value10.78M USD
Revenue (TTM)2.33M USD
Gross Profit663.71K USD
Net Income (TTM)-5.61M USD
Revenue/Share0.03 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000PIQ0
Valuation
P/E (Trailing)—
P/E (Forward)-3.83
PEG—
EV/EBITDA-1.92
EV/Revenue4.63
P/S5.64
P/B3.29
EPS (TTM)-0.05
EPS (Forward)-0.03
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin-104.02%
EBITDA Margin-241.28%
Profit Margin-844.95%
ROE-61.61%
ROA-54.90%
Growth
Revenue Growth6.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.06M USD
CapEx (TTM)20.49K USD
FCF Margin-174.61%
FCF Yield—
Net Debt-2.19M USD
Net Debt/EBITDA0.39
Balance Sheet
Debt/Equity0.02
Current Ratio3.19
Quick Ratio3.16
Book Value/Sh0.04 AUD
Cash/Share0.02 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.4300 AUD
Target Range0.4300 AUD – 0.4300 AUD
# Analysts1
Ownership
Shares Out.165.37M
Float128.14M
Insiders26.68%
Institutions7.02%
Technical
SMA 500.1416 AUD
SMA 2000.2546 AUD
Beta-0.36
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)140.59K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—